Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 755

1.

Finding the best density functional approximation to describe interaction energies and structures of ionic liquids in molecular dynamics studies.

Perlt E, Ray P, Hansen A, Malberg F, Grimme S, Kirchner B.

J Chem Phys. 2018 May 21;148(19):193835. doi: 10.1063/1.5013122.

PMID:
30307237
2.
3.

Quantitative Binding Behavior of Intrinsically Disordered Proteins to Nanoparticle Surfaces at Individual Residue Level.

Xie M, Li D, Yuan J, Hansen A, Bruschweiler R.

Chemistry. 2018 Sep 21. doi: 10.1002/chem.201804556. [Epub ahead of print]

PMID:
30240067
4.

Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care - 2-year outcomes and predictors.

Brahe CH, Krabbe S, Østergaard M, Ørnbjerg L, Glinatsi D, Røgind H, Jensen HS, Hansen A, Nørregaard J, Jacobsen S, Terslev L, Huynh TK, Jensen DV, Manilo N, Asmussen K, Brown Frandsen P, Boesen M, Rastiemadabadi Z, Morsel Carlsen L, Møller JM, Krogh NS, Hetland ML.

Rheumatology (Oxford). 2018 Aug 28. doi: 10.1093/rheumatology/key244. [Epub ahead of print]

PMID:
30169706
5.

Redetermination of the solvent-free crystal structure of l-proline.

Koenig JJ, Neudörfl JM, Hansen A, Breugst M.

Acta Crystallogr E Crystallogr Commun. 2018 Jul 10;74(Pt 8):1067-1070. doi: 10.1107/S2056989018009490. eCollection 2018 Aug 1.

6.

Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study.

Buhl ASK, Christensen TD, Christensen IJ, Nelausen KM, Balslev E, Knoop AS, Brix EH, Svensson E, Glavicic V, Luczak A, Langkjer ST, Linnet S, Jakobsen EH, Bogovic J, Ejlertsen B, Rasmussen A, Hansen A, Knudsen S, Nielsen D, Jensen PB.

Breast Cancer Res Treat. 2018 Nov;172(2):391-400. doi: 10.1007/s10549-018-4918-4. Epub 2018 Aug 11.

PMID:
30099635
7.

The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management.

Girotra M, Hansen A, Farooki A, Byun DJ, Min L, Creelan BC, Callahan MK, Atkins MB, Sharon E, Antonia SJ, West P, Gravell AE; Investigational Drug Steering Committee (IDSC) Immunotherapy Task Force collaboration.

JNCI Cancer Spectr. 2018 Jul;2(3):pky021. doi: 10.1093/jncics/pky021. Epub 2018 Jul 19. Review.

8.

Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer.

Krishnamurthy A, Dasari A, Noonan AM, Mehnert JM, Lockhart AC, Leong S, Capasso A, Stein MN, Sanoff HK, Lee JJ, Hansen A, Malhotra U, Rippke S, Gustafson DL, Pitts TM, Ellison K, Davis SL, Messersmith WA, Eckhardt SG, Lieu CH.

Cancer Res. 2018 Sep 15;78(18):5398-5407. doi: 10.1158/0008-5472.CAN-18-0316. Epub 2018 Jul 24.

PMID:
30042150
9.

Correlates of Occupational Heat-Induced Illness Costs: Case Study of South Australia 2000 to 2014.

Xiang J, Hansen A, Pisaniello D, Dear K, Bi P.

J Occup Environ Med. 2018 Sep;60(9):e463-e469. doi: 10.1097/JOM.0000000000001395.

PMID:
30020217
10.

A diuranium carbide cluster stabilized inside a C80 fullerene cage.

Zhang X, Li W, Feng L, Chen X, Hansen A, Grimme S, Fortier S, Sergentu DC, Duignan TJ, Autschbach J, Wang S, Wang Y, Velkos G, Popov AA, Aghdassi N, Duhm S, Li X, Li J, Echegoyen L, Schwarz WHE, Chen N.

Nat Commun. 2018 Jul 16;9(1):2753. doi: 10.1038/s41467-018-05210-8.

11.

How soon will digital endpoints become a cornerstone for future drug development?

Boehme P, Hansen A, Roubenoff R, Scheeren J, Herrmann M, Mondritzki T, Ehlers J, Truebel H.

Drug Discov Today. 2018 Jul 17. pii: S1359-6446(18)30166-1. doi: 10.1016/j.drudis.2018.07.001. [Epub ahead of print]

PMID:
30009955
12.

No difference in human mast cells derived from peanut allergic versus non-allergic subjects.

Larsen LF, Juel-Berg N, Hansen A, Hansen KS, Mills ENC, van Ree R, Rådinger M, Poulsen LK, Jensen BM.

Immun Inflamm Dis. 2018 Jul 10. doi: 10.1002/iid3.226. [Epub ahead of print]

13.

Trends in Weight Loss Efforts Among US Adolescents With Overweight and Obesity.

Hawkins DR, Kazmierski K, Hansen A, Reid C, Brown A, Opoku ST, Zhang J.

JAMA Pediatr. 2018 Aug 1;172(8):782-784. doi: 10.1001/jamapediatrics.2018.1012. No abstract available.

PMID:
29946680
14.

Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.

Lemoine MD, Krause T, Koivumäki JT, Prondzynski M, Schulze ML, Girdauskas E, Willems S, Hansen A, Eschenhagen T, Christ T.

Circ Arrhythm Electrophysiol. 2018 Jul;11(7):e006035. doi: 10.1161/CIRCEP.117.006035.

PMID:
29925535
15.

Clonal dynamics studied in cultured induced pluripotent stem cells reveal major growth imbalances within a few weeks.

Brenière-Letuffe D, Domke-Shibamiya A, Hansen A, Eschenhagen T, Fehse B, Riecken K, Stenzig J.

Stem Cell Res Ther. 2018 Jun 18;9(1):165. doi: 10.1186/s13287-018-0893-2.

16.

Impact of meteorological factors on hemorrhagic fever with renal syndrome in 19 cities in China, 2005-2014.

Xiang J, Hansen A, Liu Q, Tong MX, Liu X, Sun Y, Cameron S, Hanson-Easey S, Han GS, Williams C, Weinstein P, Bi P.

Sci Total Environ. 2018 Sep 15;636:1249-1256. doi: 10.1016/j.scitotenv.2018.04.407. Epub 2018 May 9.

PMID:
29913587
17.

Early metastatic colorectal cancers show increased tissue expression of miR-17/92 cluster members in the invasive tumor front.

Jepsen RK, Novotny GW, Klarskov LL, Bang-Berthelsen CH, Haakansson IT, Hansen A, Christensen IJ, Riis LB, Høgdall E.

Hum Pathol. 2018 Oct;80:231-238. doi: 10.1016/j.humpath.2018.05.027. Epub 2018 Jun 11.

PMID:
29902577
18.

Climate change adaptation: no one size fits all.

Hansen A, Bi P.

Lancet Planet Health. 2017 Dec;1(9):e353-e354. doi: 10.1016/S2542-5196(17)30160-2. Epub 2017 Dec 8. No abstract available.

19.

Donor-acceptor interactions between cyclic trinuclear pyridinate gold(i)-complexes and electron-poor guests: nature and energetics of guest-binding and templating on graphite.

Hahn R, Bohle F, Kotte S, Keller TJ, Jester SS, Hansen A, Grimme S, Esser B.

Chem Sci. 2018 Mar 5;9(14):3477-3483. doi: 10.1039/c7sc05355j. eCollection 2018 Apr 14.

20.

CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy.

Mosqueira D, Mannhardt I, Bhagwan JR, Lis-Slimak K, Katili P, Scott E, Hassan M, Prondzynski M, Harmer SC, Tinker A, Smith JGW, Carrier L, Williams PM, Gaffney D, Eschenhagen T, Hansen A, Denning C.

Eur Heart J. 2018 May 8. doi: 10.1093/eurheartj/ehy249. [Epub ahead of print]

PMID:
29741611

Supplemental Content

Loading ...
Support Center